Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
This study is currently recruiting participants.
Verified April 2013
by Memorial Sloan-Kettering Cancer Center
Study NCT00515411 Information provided by Memorial Sloan-Kettering Cancer Center
First Received on August 10, 2007. Last Updated on April 29, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Gastric Cancer
Additional conditions recognized in this trial
Adenocarcinoma
Adenocarcinoma, Mucinous
Stomach Neoplasms
More general conditions related to this trial
Carcinoma
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Cystic, Mucinous, and Serous
Neoplasms, Glandular and Epithelial
Stomach Diseases
Additional drug interventions recognized in this trial
Cisplatin
Docetaxel
Fluorouracil
Leucovorin
Levoleucovorin
More general drug interventions related to this trial
Antidotes
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Growth Substances
Immunologic Factors
Immunosuppressive Agents
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Radiation-Sensitizing Agents
Therapeutic Uses
Vitamin B Complex
Vitamins
Sponsors listed in this trial
Memorial Sloan-Kettering Cancer Center
Sanofi
Roche/Genetech
City of Hope National Medical Center
Piedmont Hospital Research Institute
Medical College of Wisconsin
Queens Health Network
Weill Medical College of Cornell University
Memorial Cancer Institute, Florida
University of Pittsburgh
Long Island Jewish Medical Center
Nebraska Cancer Specialists Methodist Estabrook Cancer Center
Back to top of Main Content
